- Datum26.04.2024
- Uhrzeit15:00 - 16:00 Uhr
- VeranstalterXTB
Du willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnenNeurocrine Biosciences Inc. Kurse
Passende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Wertentwicklung (Nasdaq)
Wikifolio
Passender Service zu Neurocrine Biosciences Inc.
Webinar zu Neurocrine Biosciences Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)89,040-148,370
- Jahrestief / Hoch ($)128,000-148,370
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Neurocrine Biosciences Inc.
Termine von Neurocrine Biosciences Inc.
- Mai1Neurocrine Biosciences Inc.Q1 2024 Earnings Release
- Jul30Neurocrine Biosciences Inc.Q2 2024 Earnings Release
- Okt29Neurocrine Biosciences Inc.Q3 2024 Earnings Release
Beschreibung
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.